Phase 3 Study Weighs Benefits of Standard Drugs Plus Surgery or Radiation Therapy

Phase 3 Study Weighs Benefits of Standard Drugs Plus Surgery or Radiation Therapy
The first patients have been enrolled in a Phase 3 clinical trial to evaluate if combining either prostate removal surgery or radiation therapy with standard systemic therapy delays cancer progression and improves survival of patients with advanced prostate cancer that has spread to other parts of the body. Enrollment has begun at the LSU Health New Orleans Scott Cancer Center. The

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *